Trafalgar International GCAN
OTC GCAN
$0.35 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Trafalgar International (GCAN) Change in Accured Expenses (2016 - 2026)

Trafalgar International (GCAN) posted Change in Accured Expenses of $30000.0 for Q1 2026, up 200.0% on a QoQ basis from $10000.0 in Q4 2025, and little changed year-over-year from $30000.0 in Q1 2025.

Analysis

Trafalgar International (GCAN) Change in Accured Expenses (2016 - 2026) Analysis & Trends

Trafalgar International has reported Change in Accured Expenses for 11 years, with the latest figure at $30000.0 in Q1 2026.

  • On a quarterly basis, Change in Accured Expenses changed 0.0% year-over-year to $30000.0 in Q1 2026; TTM through Mar 2026 was $90000.0, a 39.88% increase from a year earlier, with the FY2025 full-year figure at $90000.0, up 125.0% from the prior year.
  • Change in Accured Expenses was $30000.0 for Q1 2026 at Trafalgar International, up from $10000.0 in the prior quarter.
  • The five-year high for Change in Accured Expenses was $30000.0 in Q1 2022, with the low at -$10000.0 in Q2 2022.
  • Average Change in Accured Expenses over 5 years is $17491.2, with a median of $20000.0 recorded in 2022.
  • The largest YoY upside for Change in Accured Expenses was 433.33% in 2022 against a maximum downside of 138.46% in 2022.
  • Over 5 years, Change in Accured Expenses stood at $20000.0 in 2022, then sank by 63.25% to $7350.0 in 2023, then surged by 212.35% to $22958.0 in 2024, then tumbled by 56.44% to $10000.0 in 2025, then jumped by 200.0% to $30000.0 in 2026.
  • The last three Change in Accured Expenses figures came in at $30000.0 (Q1 2026), $10000.0 (Q4 2025), and $30000.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn 2.32 Bn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn 1.20 Bn
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn -
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn -
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn -
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn -
7 Revolution Medicines 45.00 Bn 45.00 Bn - 55.78 Mn
8 Incyte 25.47 Bn 20.94 Bn 1.57 Bn -204.33 Mn
9 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn -4.00 Mn
10 Trafalgar International 217,335.05 217,335.05 - 30,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 30,000.00
Dec 31, 2025 10,000.00
Sep 30, 2025 30,000.00
Jun 30, 2025 20,000.00
Mar 31, 2025 30,000.00
Dec 31, 2024 22,958.00
Sep 30, 2024 5,722.00
Jun 30, 2024 5,660.00
Mar 31, 2024 5,660.00
Dec 31, 2023 7,350.00
Sep 30, 2023 10,000.00
Jun 30, 2023 30,000.00
Mar 31, 2023 30,000.00
Dec 31, 2022 20,000.00
Sep 30, 2022 20,000.00
Jun 30, 2022 -10,000.00
Mar 31, 2022 30,000.00
Sep 30, 2021 -6,000.00
Jun 30, 2021 26,000.00
Mar 31, 2021 31,000.00